Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 521-18-6 | Product Number: A0462
Stanolone
Purity: >99.0%(GC)
- 5α-Androstan-17β-ol-3-one
- 5α-Dihydrotestosterone
- DHT
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | A0462 |
Purity / Analysis Method
|
>99.0%(GC) |
| Molecular Formula / Molecular Weight | C__1__9H__3__0O__2 = 290.45 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 521-18-6 |
| Reaxys Registry Number | 4295827 |
| SDBS (AIST Spectral DB) | 10771 |
| Merck Index (14) | 8793 |
| MDL Number | MFCD00003667 |
| Appearance | White to Almost white powder to crystaline |
| Purity(GC) | min. 98.0 % |
| Melting point | 179.0 to 184.0 °C |
| Specific rotation [a]20/D | +25.0 to +28.0 deg(C=1, Dioxane) |
| Solubility in hot Methanol | very faint turbidity |
| NMR | confirm to structure |
| Melting Point | 182 °C |
| Specific Rotation | 27° (C=1,Dioxane) |
| Solubility (soluble in) | Acetone, Ether, Alcohol |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H360 : May damage fertility or the unborn child. H351 : Suspected of causing cancer. |
| Precautionary Statements | P261 : Avoid breathing dust. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell. |
| EC Number | 208-307-3 |
| RTECS# | BV8052000 |
| HS Number | 2937900000 |
References
- Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells
- Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
(a review) - Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: Key enzymes in androgen metabolism
(a review) - Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia (a review)
- Androgen biosynthetic pathways in the human prostate (a review)
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.